← Back to all trials
Not Yet Recruiting
NCT05756179
Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Sex: All
Ages: 19 Years – 65 Years
Phase: PHASE3
Enrollment: 80
Sponsor: Alexandria University
Summary
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Eligibility Criteria
Inclusion Criteria:Patients with mild to moderate disease activity.Patient age must be more than 18 years.Exclusion Criteria:Pregnant and lactating females.Patients with liver, renal impairment or any other inflammatory diseases.Patients on TNF-α or IL-1β antagonists.
Source: ClinicalTrials.gov (NCT05756179). StuddyBuddy aggregates publicly available trial information.
